Latest & greatest articles for mammography

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on mammography or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on mammography and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for mammography

41. [Digital screening mammography. Critical analysis of the article by Chiarelli (2013) and literature review]

[Digital screening mammography. Critical analysis of the article by Chiarelli (2013) and literature review] Mammographie numérique de dépistage. Analyse critique de l'article de Chiarelli (2013) et revue de littérature [Digital screening mammography. Critical analysis of the article by Chiarelli (2013) and literature review] Mammographie numérique de dépistage. Analyse critique de l'article de Chiarelli (2013) et revue de littérature [Digital screening mammography. Critical analysis (...) of the article by Chiarelli (2013) and literature review] Moqadem K, Boulanger J Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Moqadem K, Boulanger J . Mammographie numérique de dépistage. Analyse critique de l'article de Chiarelli (2013) et revue de littérature . [Digital screening mammography. Critical analysis of the article by Chiarelli (2013

Health Technology Assessment (HTA) Database.2014

42. Cohort study: Some more evidence of long-term psychosocial harms from receiving false-positive screening mammography results

Cohort study: Some more evidence of long-term psychosocial harms from receiving false-positive screening mammography results Some more evidence of long-term psychosocial harms from receiving false-positive screening mammography results | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name (...) or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Some more evidence of long-term psychosocial harms from receiving false-positive screening mammography results Article Text Aetiology Cohort study Some more evidence of long-term psychosocial harms from receiving false-positive screening mammography results Jessica DeFrank 1

Evidence-Based Medicine (Requires free registration)2014 Full Text: Link to full Text with Trip Pro

43. Overdiagnosis from mammography screening

Overdiagnosis from mammography screening Overdiagnosis from mammographic screening | Cancer Australia ") //--> ") //--> Search form Search You are here » » Loading cart Revised & updated: 2014 , 2010 Published: 2008 This position statement has been endorsed by the Australian Health Ministers’ Advisory Council Standing Committee on Screening, Cancer Council Australia and the Royal Australian and New Zealand College of Radiologists, and is supported by the Cancer Australia Advisory Council (...) cancer risk factors between screened and unscreened women and what estimates are used when making these adjustments; the duration for which women are followed after screening cessation; the estimates used for lead-time effects (i.e., the time diagnosis was brought forward through screening); whether account is taken of non-diagnostic mammography outside the screening program and how this is done; death rates from other diseases and hence variations in life expectancy at time of screening; screening

Cancer Australia2014

44. Cost-effectiveness study: Estimating the cost-effectiveness of modern screening mammography programmes

Cost-effectiveness study: Estimating the cost-effectiveness of modern screening mammography programmes Estimating the cost-effectiveness of modern screening mammography programmes | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search (...) for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Estimating the cost-effectiveness of modern screening mammography programmes Article Text Economic analysis Cost-effectiveness study Estimating the cost-effectiveness of modern screening mammography programmes Jean-Luc Bulliard Statistics from Altmetric.com No Altmetric data available for this article. Commentary

Evidence-Based Medicine (Requires free registration)2014

45. Computer-aided detection (CAD) with full-field digital mammography (FFDM) for breast cancer screening

Computer-aided detection (CAD) with full-field digital mammography (FFDM) for breast cancer screening Computer-aided detection (CAD) with full-field digital mammography (FFDM) for breast cancer screening Computer-aided detection (CAD) with full-field digital mammography (FFDM) for breast cancer screening Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Computer (...) -aided detection (CAD) with full-field digital mammography (FFDM) for breast cancer screening. Lansdale: HAYES, Inc.. Directory Publication. 2014 Authors' objectives Computer-aided detection (CAD) for breast cancer screening involves the use of computer-based algorithms to identify potentially malignant abnormalities in radiographic images, which may help to reduce mortality. The goals of using CAD are to minimize false-positives that lead to unnecessary diagnostic testing and to minimize false

Health Technology Assessment (HTA) Database.2014

46. Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk.

Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk. BACKGROUND: Breast cancer is the most common malignant disease diagnosed in women worldwide. Screening with mammography has the ability to detect breast cancer at an early stage. The diagnostic accuracy of mammography screening largely depends on the radiographic density of the imaged breasts. In radiographically dense breasts, non-calcified breast cancers are more (...) likely to be missed than in fatty breasts. As a consequence, some cancers are not detected by mammography screening. Supporters of adjunct ultrasonography to the screening regimen for breast cancer argue that it might be a safe and inexpensive approach to reduce the false negative rates of the screening process. Critics, however, are concerned that performing supplemental ultrasonography on women at average risk will also increase the rate of false positive findings and can lead to unnecessary

Cochrane2013

47. Short-term outcomes of screening mammography using computer-aided detection: a population-based study of medicare enrollees.

Short-term outcomes of screening mammography using computer-aided detection: a population-based study of medicare enrollees. BACKGROUND: Computer-aided detection (CAD) has rapidly diffused into screening mammography practice despite limited and conflicting data on its clinical effect. OBJECTIVE: To determine associations between CAD use during screening mammography and the incidence of ductal carcinoma in situ (DCIS) and invasive breast cancer, invasive cancer stage, and diagnostic testing (...) . DESIGN: Retrospective cohort study. SETTING: Medicare program. PARTICIPANTS: Women aged 67 to 89 years having screening mammography between 2001 and 2006 in U.S. SEER (Surveillance, Epidemiology and End Results) regions (409 459 mammograms from 163 099 women). MEASUREMENTS: Incident DCIS and invasive breast cancer within 1 year after mammography, invasive cancer stage, and diagnostic testing within 90 days after screening among women without breast cancer. RESULTS: From 2001 to 2006, CAD prevalence

Annals of Internal Medicine2013 Full Text: Link to full Text with Trip Pro

48. Overdiagnosis in screening mammography in Denmark: population based cohort study.

Overdiagnosis in screening mammography in Denmark: population based cohort study. OBJECTIVE: To use data from two longstanding, population based screening programmes to study overdiagnosis in screening mammography. DESIGN: Population based cohort study. SETTING: Copenhagen municipality (from 1991) and Funen County (from 1993), Denmark. PARTICIPANTS: 57,763 women targeted by organised screening, aged 56-69 when the screening programmes started, and followed up to 2009. MAIN OUTCOME MEASURES

BMJ2013 Full Text: Link to full Text with Trip Pro

49. Surveillance of women at increased risk of breast cancer using mammography and clinical breast examination: further evidence of benefit

Surveillance of women at increased risk of breast cancer using mammography and clinical breast examination: further evidence of benefit Surveillance of women at increased risk of breast cancer using mammography and clinical breast examination: further evidence of benefit Surveillance of women at increased risk of breast cancer using mammography and clinical breast examination: further evidence of benefit Maurice A, Evans DG, Affen J, Greenhalgh R, Duffy SW, Howell A Record Status (...) This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study examined the cost-effectiveness of clinical breast examination, before conventional mammography, for women at a high risk of breast cancer, given their family history. The authors concluded that clinical

NHS Economic Evaluation Database.2013

50. Citations of scientific results and conflicts of interest: the case of mammography screening

Citations of scientific results and conflicts of interest: the case of mammography screening Citations of scientific results and conflicts of interest: the case of mammography screening | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search (...) for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Citations of scientific results and conflicts of interest: the case of mammography screening Article Text Original EBM Research Citations of scientific results and conflicts of interest: the case of mammography screening Kristine Rasmussen , Karsten Juhl Jørgensen , Peter C Gøtzsche Statistics from Altmetric.com

Evidence-Based Medicine (Requires free registration)2013 Full Text: Link to full Text with Trip Pro

51. Observational study: Mammography screening in Norway caused substantial overdiagnosis and did not reduce late-stage breast cancers

Observational study: Mammography screening in Norway caused substantial overdiagnosis and did not reduce late-stage breast cancers Mammography screening in Norway caused substantial overdiagnosis and did not reduce late-stage breast cancers | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user (...) name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Mammography screening in Norway caused substantial overdiagnosis and did not reduce late-stage breast cancers Article Text Online articles Observational study Mammography screening in Norway caused substantial overdiagnosis and did not reduce late-stage breast

Evidence-Based Medicine (Requires free registration)2013

52. A false-positive on screening mammography has a negative psychosocial impact up to 3?years after receiving the all clear

A false-positive on screening mammography has a negative psychosocial impact up to 3?years after receiving the all clear A false-positive on screening mammography has a negative psychosocial impact up to 3 years after receiving the all clear | Evidence-Based Mental Health This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your (...) user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here A false-positive on screening mammography has a negative psychosocial impact up to 3 years after receiving the all clear Article Text Psychosocial A false-positive on screening mammography has a negative psychosocial impact up to 3 years after receiving

Evidence-Based Mental Health2013

53. Population Screening Act: mammography in two directions as standard

Population Screening Act: mammography in two directions as standard Population Screening Act: mammography in two directions as standard Population Screening Act: mammography in two directions as standard Health Council of the Netherlands Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Health Council of the Netherlands. Population Screening Act: mammography (...) in two directions as standard. The Hague: Health Council of the Netherlands Gezondheidsraad (GR). 2013/07. 2013 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Breast Neoplasms; Early Detection of Cancer; Mammography; Mass Screenings Language Published English Country of organisation Netherlands English summary An English language summary is available. Address for correspondence Postbus 16052, 2500 BB Den Haag, The Netherlands. Tel: +31 70 340 7520;Fax: +31 70 340 7523

Health Technology Assessment (HTA) Database.2013

54. Effect of three decades of screening mammography on breast-cancer incidence.

Effect of three decades of screening mammography on breast-cancer incidence. BACKGROUND: To reduce mortality, screening must detect life-threatening disease at an earlier, more curable stage. Effective cancer-screening programs therefore both increase the incidence of cancer detected at an early stage and decrease the incidence of cancer presenting at a late stage. METHODS: We used Surveillance, Epidemiology, and End Results data to examine trends from 1976 through 2008 in the incidence (...) of early-stage breast cancer (ductal carcinoma in situ and localized disease) and late-stage breast cancer (regional and distant disease) among women 40 years of age or older. RESULTS: The introduction of screening mammography in the United States has been associated with a doubling in the number of cases of early-stage breast cancer that are detected each year, from 112 to 234 cases per 100,000 women--an absolute increase of 122 cases per 100,000 women. Concomitantly, the rate at which women present

NEJM2012

55. Use of prior mammograms in the transition to digital mammography: a performance and cost analysis

Use of prior mammograms in the transition to digital mammography: a performance and cost analysis Use of prior mammograms in the transition to digital mammography: a performance and cost analysis Use of prior mammograms in the transition to digital mammography: a performance and cost analysis Taylor-Phillips S, Wallis MG, Duncan A, Gale AG Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary (...) of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The aim was to examine the costs and the detection performance of digital mammography, with or without previous film mammograms, in the UK NHS breast screening programme. The authors concluded that either digitised or non-digitised film mammograms improved the performance of digital screening and saved costs by reducing the number of normal cases who

NHS Economic Evaluation Database.2012

56. Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 Years: A Comparative Modeling Study of Risk.

Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 Years: A Comparative Modeling Study of Risk. BACKGROUND: Timing of initiation of screening for breast cancer is controversial in the United States. OBJECTIVE: To determine the threshold relative risk (RR) at which the harm-benefit ratio of screening women aged 40 to 49 years equals that of biennial screening for women aged 50 to 74 years. DESIGN: Comparative modeling study. DATA SOURCES: Surveillance (...) , Epidemiology, and End Results program, Breast Cancer Surveillance Consortium, and medical literature. TARGET POPULATION: A contemporary cohort of women eligible for routine screening. TIME HORIZON: Lifetime. PERSPECTIVE: Societal. INTERVENTION: Mammography screening starting at age 40 versus 50 years with different screening methods (film, digital) and screening intervals (annual, biennial). OUTCOME MEASURES: BENEFITS: life-years gained, breast cancer deaths averted; harms: false-positive mammography

Annals of Internal Medicine2012 Full Text: Link to full Text with Trip Pro

57. Overdiagnosis of invasive breast cancer due to mammography screening: results from the norwegian screening program.

Overdiagnosis of invasive breast cancer due to mammography screening: results from the norwegian screening program. BACKGROUND: Precise quantification of overdiagnosis of breast cancer (defined as the percentage of cases of cancer that would not have become clinically apparent in a woman's lifetime without screening) due to mammography screening has been hampered by lack of valid comparison groups that identify incidence trends attributable to screening versus those due to temporal trends (...) in incidence. OBJECTIVE: To estimate the percentage of overdiagnosis of breast cancer attributable to mammography screening. DESIGN: Comparison of invasive breast cancer incidence with and without screening. SETTING: A nationwide mammography screening program in Norway (inviting women aged 50 to 69 years), gradually implemented from 1996 to 2005. PARTICIPANTS: The Norwegian female population. MEASUREMENTS: Concomitant incidence of invasive breast cancer from 1996 to 2005 in counties where the screening

Annals of Internal Medicine2012

58. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness

Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness Schousboe JT, Kerlikowske K, Loh A, Cummings SR Record Status This is a critical (...) abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study assessed the cost-effectiveness of breast cancer screening, using mammography, at different intervals taking account of risk factors, such as age, breast density, history of breast biopsy, and family history

NHS Economic Evaluation Database.2012

60. Understanding recent trends in incidence of invasive breast cancer in Norway: age-period-cohort analysis based on registry data on mammography screening and hormone treatment use.

Understanding recent trends in incidence of invasive breast cancer in Norway: age-period-cohort analysis based on registry data on mammography screening and hormone treatment use. OBJECTIVE: To quantify the separate contributions of menopausal hormone treatment and mammography screening activities on trends in incidence of invasive breast cancer between 1987 and 2008. DESIGN: Population study using aggregated data analysed by an extended age-period-cohort model. SETTING: Norway. Population (...) Norwegian women aged 30-90 between 1987 and 2008, including 50,102 newly diagnosed cases of invasive breast cancer. Main outcomes measures Attributable proportions of mammography screening and hormone treatment to recent incidence of invasive breast cancer, and the remaining variation in incidence after adjustment for mammography screening and hormone treatment. RESULTS: The incidence of invasive breast cancer in Norway increased steadily until 2002, levelled off, and then declined from 2006. All non

BMJ2012 Full Text: Link to full Text with Trip Pro